Trastuzumab emtansine versus treatment of physician’s choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial - Krop, I E; Kim, S B; González-Martín, A (Lancet Oncol, 2014)
et al.